US Patent 11439592 Ocular implant containing a tyrosine kinase inhibitor
Article
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.